Journal Of Neuroimmune Pharmacology

Journal Title：Journal Of Neuroimmune Pharmacology

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.

《神经免疫药理学杂志》旨在促进神经系统药理学和免疫学领域新发现和重要发现的传播、关注和交流。该杂志的目标与神经免疫药理学学会的目标相似，即通过增加对受免疫系统影响的神经和神经精神疾病（反之亦然）的根本理解，以及采取药理措施，以更好地理解疾病机制或改善疾病结果。JNIP 的范围包括所有关于受免疫紊乱影响的神经免疫和神经系统疾病的病因、预防和治疗的主要著作和评论。欢迎原创研究，以定义神经免疫调节环境或内源性线索，如毒素和滥用药物、激素和细胞因子。JNIP 将成为连接药理学、免疫学和神经科学领域的可靠跨学科信息来源。

Journal Of Neuroimmune Pharmacology创刊于2006年，由Springer US出版商出版，收稿方向涵盖医学 - 神经科学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 较慢,6-12周 ，影响因子指数5.2，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。